5 Dumbest Things on...
Health Care: Drugs
Synthetic Biologics Inc (SYN: AMEX)
$1.39 0.01 | 0.73%
05/24/13 - 11:07 AM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| SYN | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -16.57 | -17.37 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -1.00 | 0.00 | |
| Net Income | 3.63 | 0.00 | |
| EPS | 1.72 | 0.00 |
Earnings for SYN:
| EBITDA | -17.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.05 | $-0.06 | $-0.27 | $-0.31 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $-0.05 | $-0.06 | $-0.22 | $-0.23 |
| Low Estimate | $-0.06 | $-0.07 | $-0.31 | $-0.40 |
| Prior Year | $-0.05 | $-0.05 | $-0.50 | $-0.27 |
| Growth Rate (Year over Year) | -10.00% | -30.00% | 47.00% | -18.87% |
Portfolios with SYN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest SYN Headlines from TheStreet
- 3 Biotech Stocks Under $5 Moving Higher 02.07.13 | 02:02 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- Synovus To Raise $350M in Stock Offer 09.14.09 | 11:09 pm
- Regions' Profit Stung by Fla. Real Estate 07.22.08 | 11:07 am
- Stock Upgrades, Downgrades from TheStreet.com Ratings 11.21.07 | 01:11 pm
- Cramer's 'Mad Money Lightning Round': Best BuyBuyBuy 10.01.07 | 07:10 pm
- Neurocrine Says Sleeping Pill Data Are Good 11.14.02 | 09:11 am
Press Releases for SYN
- Synthetic Biologics To Present At The 2nd Annual Marcum LLP MicroCap Conference - PR Newswire 05.21.13 | 07:05 am
- Synthetic Biologics Reiterates That The Infectious Disease Collaboration With Intrexon Remains In Effect - PR Newswire 04.19.13 | 07:04 pm
- Synthetic Biologics Announces Issuance Of U.S. Patent Covering Combination Of Estriol And Copaxone® For Multiple Sclerosis - PR Newswire 04.04.13 | 01:04 pm
- Synthetic Biologics To Present At The 25th Annual ROTH Conference - PR Newswire 03.12.13 | 07:03 am
- Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics' Scientific Advisory Board - PR Newswire 02.26.13 | 07:02 am
- Synthetic Biologics Reports That Flupirtine Sublicensee, Meda AB, To Initiate Phase II Fibromyalgia Clinical Trial In U.S. - PR Newswire 02.22.13 | 07:02 am
- Synthetic Biologics To Present At The 2013 BIO CEO & Investor Conference - PR Newswire 02.05.13 | 07:02 am
- Synthetic Biologics To Present At OneMedForum San Francisco 2013 - PR Newswire 01.07.13 | 07:01 am
- Synthetic Biologics And Intrexon Corporation Initiate Development Of Monoclonal Antibodies For Whooping Cough (Pertussis) - PR Newswire 12.20.12 | 04:12 pm
- Synthetic Biologics Closes Deal For Acquisition Of C. Difficile Infectious Disease Program - PR Newswire 12.03.12 | 02:12 pm
Partner Headlines for SYN
